Regulator of calcineurin 1 mediates pathological vascular wall remodeling

Journal of Experimental Medicine

Volumn 208, Issue 10, 2011, Pages 2125-2139

  Esteban, Vanesa ^a   Méndez Barbero, Nerea ^a   Jiménez Borreguero, Luis Jesús ^b   Roqué, Mercè ^c   Novensá, Laura ^c   García Redondo, Ana Belén ^d   Salaices, Mercedes ^d   Vila, Luis ^e   Arbonés, María L ^f   Campanero, Miguel R ^g   Redondo, Juan Miguel ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^f INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

^g INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CALCINEURIN; CALCINEURIN 1; CD3 ANTIGEN; LENTIVIRUS VECTOR; PROTEIN MAC3; PROTEIN RCAN; SMOOTH MUSCLE ACTIN; TUBULIN; UNCLASSIFIED DRUG; VIMENTIN;

ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CONTROLLED STUDY; GENE; GENOME ANALYSIS; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RCAN1 GENE; RESTENOSIS; SIGNAL TRANSDUCTION; TUNICA MEDIA; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASCULAR WALL REMODELING;

ANEURYSM; ANGIOTENSIN II; ANIMALS; AORTA; CALCINEURIN; CELL MOVEMENT; CORONARY RESTENOSIS; CYCLOSPORINE; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; NFATC TRANSCRIPTION FACTORS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 80555139632     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20110503     Document Type: Article

References (84)

1. Abbasi, S., J.D. Lee, B. Su, X. Chen, J.L. Alcon, J. Yang, R.E. Kellems, and Y. Xia. 2006. Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. J. Biol. Chem. 281:7717-7726. http://dx.doi.org/10.1074/jbc.M510775200
2. Aramburu, J., M.B. Yaffe, C. López-Rodríguez, L.C. Cantley, P.G. Hogan, and A. Rao. 1999. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science. 285:2129-2133. http://dx.doi.org/10.1126/science.285.5436.2129
3. Baek, K.H., A. Zaslavsky, R.C. Lynch, C. Britt, Y. Okada, R.J. Siarey, M.W. Lensch, I.H. Park, S.S. Yoon, T. Minami, et al. 2009. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature. 459:1126-1130. http://dx.doi.org/10.1038/nature08062
4. Benigni, A., P. Cassis, and G. Remuzzi. 2010. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2:247- 257. http://dx.doi.org/10.1002/emmm.201000080
5. Berk, B.C. 2001. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol. Rev. 81:999-1030.
6. Berk, B.C., V. Vekshtein, H.M. Gordon, and T. Tsuda. 1989. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 13:305-314.
7. Bhatia, V., R. Bhatia, and M. Dhindsa. 2004. Drug-eluting stents: new era and new concerns. Postgrad. Med. J. 80:13-18. http://dx.doi.org/10.1136/pmj.2003.009431
8. Bolstad, B.M., R.A. Irizarry, M. Astrand, and T.P. Speed. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 19:185-193. http://dx.doi.org/10.1093/bioinformatics/19.2.185
9. Cano, E., A. Canellada, T. Minami, T. Iglesias, and J.M. Redondo. 2005. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway. J. Biol. Chem. 280:29435-29443. http://dx.doi.org/10.1074/jbc.M506205200
10. Cardenas, M.E., R.S. Muir, T. Breuder, and J. Heitman. 1995. Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. EMBO J. 14:2772-2783.
11. Casscells, W. 1992. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation. 86:723-729.
12. Chaikof, E.L., D.C. Brewster, R.L. Dalman, M.S. Makaroun, K.A. Illig, G.A. Sicard, C.H. Timaran, G.R. Upchurch Jr., and F.J. Veith. 2009. SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J. Vasc. Surg. 50:880-896. http://dx.doi.org/10.1016/j.jvs.2009.07.001
13. Cho, Y.J., M. Abe, S.Y. Kim, and Y. Sato. 2005. Raf-1 is a binding partner of DSCR1. Arch. Biochem. Biophys. 439:121-128. http://dx.doi.org/10.1016/j.abb.2005.05.002
14. Crabtree, G.R., and E.N. Olson. 2002. NFAT signaling: choreographing the social lives of cells. Cell. 109:S67-S79. http://dx.doi.org/10.1016/S0092-8674(02)00699-2
15. Curci, J.A. 2009. Digging in the "soil" of the aorta to understand the growth of abdominal aortic aneurysms. Vascular. 17:S21-S29. http://dx.doi.org/10.2310/6670.2008.00085
16. Daugherty, A., and L.A. Cassis. 2004. Mouse models of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 24:429-434. http://dx.doi.org/10.1161/01.ATV.0000118013.72016.ea
17. Daugherty, A., M.W. Manning, and L.A. Cassis. 2000. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105:1605-1612. http://dx.doi.org/10.1172/JCI7818
18. Davies, K.J., G. Ermak, B.A. Rothermel, M. Pritchard, J. Heitman, J. Ahnn, F. Henrique-Silva, D. Crawford, S. Canaider, P. Strippoli, et al. 2007. Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J. 21:3023-3028. http://dx.doi.org/10.1096/fj.06-7246com
19. Eichler, G.S., S. Huang, and D.E. Ingber. 2003. Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics. 19:2321-2322. http://dx.doi.org/10.1093/bioinformatics/btg307
20. Emori, T., Y. Hirata, K. Ohta, M. Shichiri, and F. Marumo. 1989. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun. 160:93-100. http://dx.doi.org/10.1016/0006-291X(89)91625-2
21. Esteban, V., O. Lorenzo, M. Rupérez, Y. Suzuki, S. Mezzano, J. Blanco, M. Kretzler, T. Sugaya, J. Egido, and M. Ruiz-Ortega. 2004. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15:1514-1529. http://dx.doi.org/10.1097/01.ASN.0000130564.75008.F5
22. Forte, A., A. Della Corte, M. De Feo, F. Cerasuolo, and M. Cipollaro. 2010. Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm. Cardiovasc. Res. 88:395-405. http://dx.doi.org/10.1093/cvr/cvq224
23. Fuentes, J.J., M.A. Pritchard, and X. Estivill. 1997. Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics. 44:358-361. http://dx.doi.org/10.1006/geno.1997.4866
24. Gavrila, D., W.G. Li, M.L. McCormick, M. Thomas, A. Daugherty, L.A. Cassis, F.J. Miller Jr., L.W. Oberley, K.C. Dellsperger, and N.L. Weintraub. 2005. Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25:1671-1677. http://dx.doi.org/10.1161/01.ATV.0000172631.50972.0f
25. Geisterfer, A.A., M.J. Peach, and G.K. Owens. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-756.
26. Genescà, L., A. Aubareda, J.J. Fuentes, X. Estivill, S. De La Luna, and M. Pérez-Riba. 2003. Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. Biochem. J. 374:567-575. http://dx.doi.org/10.1042/BJ20030267
27. Goetze, S., X.P. Xi, H. Kawano, T. Gotlibowski, E. Fleck, W.A. Hsueh, and R.E. Law. 1999. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 33:798-806. http://dx.doi.org/10.1097/00005344-199905000-00018
28. Graef, I.A., F. Chen, L. Chen, A. Kuo, and G.R. Crabtree. 2001. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell. 105:863-875. http://dx.doi.org/10.1016/S0092-8674(01)00396-8
29. Graef, I.A., F. Wang, F. Charron, L. Chen, J. Neilson, M. Tessier-Lavigne, and G.R. Crabtree. 2003. Neurotrophins and netrins require calcineurin/ NFAT signaling to stimulate outgrowth of embryonic axons. Cell. 113:657-670. http://dx.doi.org/10.1016/S0092-8674(03)00390-8
30. Greene, E.L., G. Lu, D. Zhang, and B.M. Egan. 2001. Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration. Hypertension. 37:308-312.
31. Guo, J., H. Chen, J. Ho, J. Mancini, T. Sontag, S.A. Laporte, D.E. Richard, and J.J. Lebrun. 2009. TGFbeta-induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration. Cell. Signal. 21:899-905. http://dx.doi.org/10.1016/j.cellsig.2009.01.037
32. Heeneman, S., J.C. Sluimer, and M.J. Daemen. 2007. Angiotensin-converting enzyme and vascular remodeling. Circ. Res. 101:441-454. http://dx.doi.org/10.1161/CIRCRESAHA.107.148338
33. Heit, J.J., A.A. Apelqvist, X. Gu, M.M. Winslow, J.R. Neilson, G.R. Crabtree, and S.K. Kim. 2006. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature. 443:345-349. http://dx.doi.org/10.1038/nature05097
34. Hoeffer, C.A., A. Dey, N. Sachan, H. Wong, R.J. Patterson, J.M. Shelton, J.A. Richardson, E. Klann, and B.A. Rothermel. 2007. The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. J. Neurosci. 27:13161- 13172. http://dx.doi.org/10.1523/JNEUROSCI.3974-07.2007
35. Hogan, P.G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17:2205-2232. http://dx.doi.org/10.1101/gad.1102703
36. Iakovou, I., T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, et al. 2005. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 293:2126-2130. http://dx.doi.org/10.1001/jama.293.17.2126
37. Jain, J., Z. Miner, and A. Rao. 1993. Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J. Immunol. 151:837-848.
38. Kiani, A., A. Rao, and J. Aramburu. 2000. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity. 12:359- 372. http://dx.doi.org/10.1016/S1074-7613(00)80188-0
39. Kingsbury, T.J., and K.W. Cunningham. 2000. A conserved family of calcineurin regulators. Genes Dev. 14:1595-1604.
40. Lee, E.J., S.R. Seo, J.W. Um, J. Park, Y. Oh, and K.C. Chung. 2008. NFkappaB-inducing kinase phosphorylates and blocks the degradation of Down syndrome candidate region 1. J. Biol. Chem. 283:3392-3400. http://dx.doi.org/10.1074/jbc.M706707200
41. Li, F., C. Zhang, S. Schaefer, A. Estes, and K.U. Malik. 2005. ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery. Am. J. Physiol. Heart Circ. Physiol. 289:H2592-H2601. http://dx.doi.org/10.1152/ajpheart.00450.2005
42. Liu, J., J.D. Farmer Jr., W.S. Lane, J. Friedman, I. Weissman, and S.L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:807-815. http://dx.doi.org/10.1016/0092-8674(91)90124-H
43. Liu, J., E.S. Masuda, L. Tsuruta, N. Arai, and K. Arai. 1999. Two independent calcineurin-binding regions in the N-terminal domain of murine NF-ATx1 recruit calcineurin to murine NF-ATx1. J. Immunol. 162:4755-4761.
44. Liu, Q., J.C. Busby, and J.D. Molkentin. 2009. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat. Cell Biol. 11:154-161. http://dx.doi.org/10.1038/ncb1823
45. Liu, Z., C. Zhang, N. Dronadula, Q. Li, and G.N. Rao. 2005. Blockade of nuclear factor of activated T cells activation signaling suppresses balloon injury-induced neointima formation in a rat carotid artery model. J. Biol. Chem. 280:14700-14708. http://dx.doi.org/10.1074/jbc.M500322200.
46. Maiellaro, K., and W.R. Taylor. 2007. The role of the adventitia in vascular inflammation. Cardiovasc. Res. 75:640-648. http://dx.doi.org/10.1016/j.cardiores.2007.06.023
47. Martin-McNulty, B., J. Vincelette, R. Vergona, M.E. Sullivan, and Y.X. Wang. 2005. Noninvasive measurement of abdominal aortic aneurysms in intact mice by a high-frequency ultrasound imaging system. Ultrasound Med. Biol. 31:745-749. http://dx.doi.org/10.1016/j.ultrasmedbio.2005.02.012
48. Martínez-Martínez, S., and J.M. Redondo. 2004. Inhibitors of the calcineurin/ NFAT pathway. Curr. Med. Chem. 11:997-1007. http://dx.doi.org/10.2174/0929867043455576
49. Martínez-Martínez, S., A. Rodríguez, M.D. López-Maderuelo, I. Ortega-Pérez, J. Vázquez, and J.M. Redondo. 2006. Blockade of NFAT activation by the second calcineurin binding site. J. Biol. Chem. 281:6227-6235. http://dx.doi.org/10.1074/jbc.M513885200
50. Marx, S.O., and A.R. Marks. 2001. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation. 104: 852-855.
51. Minami, T., K. Horiuchi, M. Miura, M.R. Abid, W. Takabe, N. Noguchi, T. Kohro, X. Ge, H. Aburatani, T. Hamakubo, et al. 2004. Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J. Biol. Chem. 279:50537-50554. http://dx.doi.org/10.1074/jbc.M406454200
52. Minami, T., K. Yano, M. Miura, M. Kobayashi, J. Suehiro, P.C. Reid, T. Hamakubo, S. Ryeom, W.C. Aird, and T. Kodama. 2009. The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice. J. Clin. Invest. 119:2257-2270.
53. Molkentin, J.D., J.R. Lu, C.L. Antos, B. Markham, J. Richardson, J. Robbins, S.R. Grant, and E.N. Olson. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:215-228. http://dx.doi.org/10.1016/S0092-8674(00)81573-1
54. Naftilan, A.J., R.E. Pratt, and V.J. Dzau. 1989. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1419-1424. http://dx.doi.org/10.1172/JCI114032
55. Nagata, D., R. Takeda, M. Sata, H. Satonaka, E. Suzuki, T. Nagano, and Y. Hirata. 2004. AMP-activated protein kinase inhibits angiotensin IIstimulated vascular smooth muscle cell proliferation. Circulation. 110:444-451. http://dx.doi.org/10.1161/01.CIR.0000136025.96811.76
56. Owens, G.K. 1989. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am. J. Physiol. 257:H1755-H1765.
57. Owens, G.K. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-517.
58. Porta, S., S.A. Serra, M. Huch, M.A. Valverde, F. Llorens, X. Estivill, M.L. Arbonés, and E. Martí. 2007. RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration. Hum. Mol. Genet. 16:1039-1050. http://dx.doi.org/10.1093/hmg/ddm049
59. Rodríguez, A., J. Roy, S. Martínez-Martínez, M.D. López-Maderuelo, P. Niño-Moreno, L. Ortí, D. Pantoja-Uceda, A. Pineda-Lucena, M.S. Cyert, and J.M. Redondo. 2009. A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. Mol. Cell. 33:616-626. http://dx.doi.org/10.1016/j.molcel.2009.01.030
60. Roque, M., J.T. Fallon, J.J. Badimon, W.X. Zhang, M.B. Taubman, and E.D. Reis. 2000. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler. Thromb. Vasc. Biol. 20:335-342. http://dx.doi.org/10.1161/01.ATV.20.2.335
61. Rothermel, B., R.B. Vega, J. Yang, H. Wu, R. Bassel-Duby, and R.S. Williams. 2000. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J. Biol. Chem. 275:8719-8725. http://dx.doi.org/10.1074/jbc.275.12.8719
62. Rothermel, B.A., T.A. McKinsey, R.B. Vega, R.L. Nicol, P. Mammen, J. Yang, C.L. Antos, J.M. Shelton, R. Bassel-Duby, E.N. Olson, and R.S. Williams. 2001. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA. 98:3328-3333. http://dx.doi.org/10.1073/pnas.041614798
63. Ryeom, S., R.J. Greenwald, A.H. Sharpe, and F. McKeon. 2003. The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nat. Immunol. 4:874-881. http://dx.doi.org/10.1038/ni966
64. Ryeom, S., K.H. Baek, M.J. Rioth, R.C. Lynch, A. Zaslavsky, A. Birsner, S.S. Yoon, and F. McKeon. 2008. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell. 13:420-431. http://dx.doi.org/10.1016/j.ccr.2008.02.018
65. Sakalihasan, N., R. Limet, and O.D. Defawe. 2005. Abdominal aortic aneurysm. Lancet. 365:1577-1589. http://dx.doi.org/10.1016/S0140-6736(05)66459-8
66. Sartore, S., R. Franch, M. Roelofs, and A. Chiavegato. 1999. Molecular and cellular phenotypes and their regulation in smooth muscle. Rev. Physiol. Biochem. Pharmacol. 134:235-320.
67. Sartore, S., A. Chiavegato, E. Faggin, R. Franch, M. Puato, S. Ausoni, and P. Pauletto. 2001. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ. Res. 89:1111-1121. http://dx.doi.org/10.1161/hh2401.100844
68. Satoh, K., P. Nigro, T. Matoba, M.R. O'Dell, Z. Cui, X. Shi, A. Mohan, C. Yan, J. Abe, K.A. Illig, and B.C. Berk. 2009. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat. Med. 15:649-656. http://dx.doi.org/10.1038/nm.1958
69. Satonaka, H., E. Suzuki, H. Nishimatsu, S. Oba, R. Takeda, A. Goto, M. Omata, T. Fujita, R. Nagai, and Y. Hirata. 2004. Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation. Circ. Res. 94:693-700. http://dx.doi.org/10.1161/01.RES.0000118250.67032.5E
70. Sayeski, P.P., and M.S. Ali. 2003. The critical role of c-Src and the Shc/ Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation. Exp. Cell Res. 287:339-349. http://dx.doi.org/10.1016/S0014-4827(03)00154-X
71. Schwartz, S.M. 1997. Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. J. Clin. Invest. 99:2814-2816. http://dx.doi.org/10.1172/JCI119472
72. Schwartz, S.M., D. deBlois, and E.R. O'Brien. 1995. The intima. Soil for atherosclerosis and restenosis. Circ. Res. 77:445-465.
73. Scott-Burden, T., T.J. Resink, A.W. Hahn, and P.M. Vanhoutte. 1991. Induction of endothelin secretion by angiotensin II: effects on growth and synthetic activity of vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 17:S96-S100. http://dx.doi.org/10.1097/00005344-199100177-00025
74. Shin, S.Y., H.W. Yang, J.R. Kim, W. Do Heo, and K.H. Cho. 2011. A hidden incoherent switch regulates RCAN1 in the calcineurin-NFAT signaling network. J. Cell Sci. 124:82-90. http://dx.doi.org/10.1242/jcs.076034
75. Smyth, G.K. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:e3.
76. Suzuki, E., H. Nishimatsu, H. Satonaka, K. Walsh, A. Goto, M. Omata, T. Fujita, R. Nagai, and Y. Hirata. 2002. Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T celldependent transcriptional activation in vascular myocytes. Circ. Res. 90: 1004-1011. http://dx.doi.org/10.1161/01.RES.0000017629.70769.CC
77. Touyz, R.M. 2005. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp. Physiol. 90:449-455. http://dx.doi.org/10.1113/expphysiol.2005.030080
78. van Kleef, E.M., J. Fingerle, and M.J. Daemen. 1996. Angiotensin IIinduced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated. Arterioscler. Thromb. Vasc. Biol. 16:857-863. http://dx.doi.org/10.1161/01.ATV.16.7.857
79. Vega, R.B., B.A. Rothermel, C.J. Weinheimer, A. Kovacs, R.H. Naseem, R. Bassel-Duby, R.S. Williams, and E.N. Olson. 2003. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc. Natl. Acad. Sci. USA. 100:669-674. http://dx.doi.org/10.1073/pnas.0237225100
80. Waseda, K., A. Miyazawa, J. Ako, T. Hasegawa, I. Tsujino, R. Sakurai, P.G. Yock, Y. Honda, D.E. Kandzari, M.B. Leon, and P.J. Fitzgerald; ENDEAVOR IV Trial Investigators. 2009. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc. Interv. 2:779-784.http://dx.doi.org/10.1016/j.jcin.2009.05.015
81. Watanabe, T., R. Pakala, T. Katagiri, and C.R. Benedict. 2001. Serotonin potentiates angiotensin II-induced vascular smooth muscle cell proliferation. Atherosclerosis. 159:269-279. http://dx.doi.org/10.1016/S0021-9150(01)00505-6
82. Weintraub, N.L. 2009. Understanding abdominal aortic aneurysm. N. Engl. J. Med. 361:1114-1116. http://dx.doi.org/10.1056/NEJMcibr0905244
83. Yang, Y.J., W. Chen, A. Edgar, B. Li, J.D. Molkentin, J.N. Berman, and T.J. Lin. 2009. Rcan1 negatively regulates Fc epsilonRI-mediated signaling and mast cell function. J. Exp. Med. 206:195-207. http://dx.doi.org/10.1084/jem.20081140
84. Yellaturu, C.R., S.K. Ghosh, R.K. Rao, L.K. Jennings, A. Hassid, and G.N. Rao. 2002. A potential role for nuclear factor of activated T-cells in receptor tyrosine kinase and G-protein-coupled receptor agonist-induced cell proliferation. Biochem. J. 368:183-190. http://dx.doi.org/10.1042/BJ20020347